Caplin Point Laboratories

Caplin Point Laboratories Diluted EPS

The Diluted Earnings per Share of Caplin Point Laboratories (CAPLIPOINT.NS) as of Oct 11, 2026 is 70.39 INR. In the previous year, Diluted Earnings per Share was 59.83 INR — a change of 17.65% (higher).

Diluted EPS

70.39INR

YoY

17.65%

Last updated:

Diluted Earnings per Share of Caplin Point Laboratories is 2025 70.39 INR. Diluted Earnings per Share of Caplin Point Laboratories was 2024 59.83 INR. It decreases by 17.65% higher compared to the previous year.

The Caplin Point Laboratories Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
19.05 INR
Jan 1, 2019
23.16 INR
Jan 1, 2020
28.22 INR
Jan 1, 2021
31.71 INR
Jan 1, 2022
39.22 INR
Jan 1, 2023
49.41 INR
Jan 1, 2024
59.83 INR
Jan 1, 2025
70.39 INR
The Caplin Point Laboratories Diluted EPS history
YEARDiluted EPSYoY
70.39INR+17.65%
59.83INR+21.10%
49.41INR+25.98%
39.22INR+23.68%
31.71INR+12.37%
28.22INR+21.86%
23.16INR+21.54%
19.05INR+51.36%
12.59INR+108.18%
6.05INR+11.39%
5.43INR+58.55%
3.42INR—
Access this data via the Eulerpool API

Caplin Point Laboratories Stock analysis

What does Caplin Point Laboratories do? Caplin Point Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caplin Point Laboratories stock

Diluted Earnings per Share of Caplin Point Laboratories is 70.39 INR in 2025.

Diluted Earnings per Share of Caplin Point Laboratories changed from 59.83 INR to 70.39 INR, representing a 17.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Caplin Point Laboratories since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

Income Statement — Caplin Point Laboratories

All Key Metrics — Caplin Point Laboratories